Mathew Blackman
Stock Analyst at Stifel
(3.29)
# 1,035
Out of 5,050 analysts
61
Total ratings
54.76%
Success rate
14.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.99 | +0.14% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $16.26 | +90.65% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $266.19 | +19.46% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $15.81 | +58.13% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $26.30 | -4.94% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $319.82 | -8.39% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $83.89 | +12.05% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $14.96 | +60.43% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.71 | +75.44% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $55.00 | +81.82% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $19.80 | -19.19% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.50 | +15.79% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.99
Upside: +0.14%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $16.26
Upside: +90.65%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $266.19
Upside: +19.46%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $15.81
Upside: +58.13%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $26.30
Upside: -4.94%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $319.82
Upside: -8.39%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $83.89
Upside: +12.05%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $14.96
Upside: +60.43%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.71
Upside: +75.44%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $55.00
Upside: +81.82%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $19.80
Upside: -19.19%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.50
Upside: +15.79%